Synthetic cannabinoids (SC) are designer drugs that aim to mimic the pharmacological effect of the natural cannabinoid (−)-trans-Δ9-tetrahydrocannabinol (THC). Many SCs have an even higher binding affinity to the CB1 receptor, which is responsible for the psychoactive effects, than THC.[1] In the early 2000s, before SCs and other designer drugs were categorically illegalized by new NPS legislations, they were semi-legally sold as herbal incense mixtures, called "spice", consisting of dried plant material with sprayed on SCs.
There is a lot more to talk about SCs, but I'll keep that for future blog posts.
The compounds I picked for today's blog do vary only very slightly from each other in their molecular structure. For 5F-PB-22 only one hydrogen atom of the terminal CH3 group in the alkyl chain is formally exchanged with a fluorine atom compared to PB-22. NM2201 does have a naphtyl substituent attached to the ester function instead of the 8-quinolinyl fragment in 5F-PB-22 and PB-22. Formally, one nitrogen atom is exchanged with a carbon atom. So, I think it is fair to say that these compounds are very similar in their molecular structure.
Now, importantly, as we have discussed before in another blog post and a recent publication similar compounds result in similar 1H NMR spectra, which is the reason why benchtop NMR gives great possibilities for flagging new designer drugs. At first glance it might even not be easy to spot the differences in the spectra of these compounds, so let me guide you through this.